Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

In the past decade, molecular-targeted drugs have been focused upon for the treatment of cancer. In 2002, gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor became available in Japan for the treatment of non-small cell lung cancer (NSCLC). Over 80% of selected patients,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Araki, Takuya, Yashima, Hideaki, Shimizu, Kimihiro, Aomori, Tohru, Hashita, Tadahiro, Kaira, Kyoichi, Nakamura, Tomonori, Yamamoto, Koujirou
Format: Artigo
Langue:Inglês
Publié: Libertas Academica 2012
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520446/
https://ncbi.nlm.nih.gov/pubmed/23239933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S7340
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires